The AI Capex Cycle: Why Lam Research Is the Real Bet
MetaMoon
$6.72 billion. That is the number that broke the tape. Lam Research just posted a record quarter, up 30% year-over-year, and guided to $8.1 billion for the next one. The market barely blinked. I blinked. Because that guidance is not a number. It is a signal buried in the order book of the world's most advanced fabs. Code is law, but math is the judge. And the math here says something most equity narratives are missing.
Let me strip the narrative down to the mechanics. Lam Research is not a chip designer. It does not sell CPUs or GPUs. It sells the machines that make the machines. Etch tools. Deposition tools. The precision equipment that carves transistors into silicon at the atomic scale. When TSMC or Samsung or Intel decides to build a 3nm or 2nm line, they do not call a marketing agency. They call Lam Research. Or Applied Materials. Or Tokyo Electron. There are only three or four names on that list. That is the oligopoly. That is the moat.
Here is the part most retail analysis gets wrong. The AI trade is not about the chip. It is about the capex that builds the chip. NVIDIA sells the H100. But before the H100 exists, someone has to etch the gate-all-around structures, deposit the high-k metal gates, and bond the chiplets together with hybrid bonding. That someone is Lam Research. Every AI data center build-out is a direct transfer of capital into the equipment supply chain. The chip is the headline. The equipment is the toll booth.
My own experience in this market has taught me to look at the plumbing, not the narrative. In 2020, I was running arbitrage scripts on Uniswap V2, watching the mempool for large swaps. The lesson was simple: the edge is in the execution layer, not the story. The same principle applies here. The story is AI. The execution layer is the equipment. And the equipment is sold out.
Let me break down the order flow. The $8.1 billion guide is not a hope. It is a backlog. These are purchase orders already signed by the world's top five fabs. TSMC, Samsung, Intel, SK Hynix, Micron. That concentration is a risk, but it is also a confirmation. When the top five memory and logic players are all buying the same tools at the same time, you are not looking at a single customer's whim. You are looking at a synchronized capex cycle. And that cycle is being driven by one thing: AI compute demand.
Now, the contrarian angle. Everyone is watching the chip names. The smart money is watching the lead times. Lam Research's delivery cycle is six to twelve months. That means the equipment shipped today is the capacity that comes online in 2026. The $8.1 billion guide is not just a revenue number. It is a map of future supply. And that map has a warning label. If all this capacity comes online in 12 to 18 months, and AI demand does not grow into it, you get an oversupply event. The equipment cycle is a leading indicator. The chip cycle is a lagging one. The market is pricing the boom. It is not pricing the hangover.
But here is the thing about hangovers. They are survivable if you are the one selling the alcohol. Lam Research's service revenue is the hidden profit engine. Maintenance contracts, spare parts, process optimization. That is roughly 30% of total revenue, and it carries a higher margin than the equipment itself. When the capex cycle turns, the service revenue does not disappear. It becomes the floor. This is the part of the business model that the PE ratio does not capture. The market sees a cyclical. The balance sheet says otherwise.
Let me talk about the geopolitical layer, because it is the variable that most models get wrong. Lam Research is not on the entity list. But its China revenue has dropped from 20% to 15% of total sales due to export controls. That is a real headwind. But it is being offset by the CHIPS Act build-out in the US, the European Chip Act, and Japan's 2nm push. The equipment market is being reshaped into a dual-track system. Western fabs buy Western tools. Chinese fabs buy Chinese tools. The question is whether the Chinese tools are good enough. In mature nodes, 28nm and above, yes. In advanced nodes, 5nm and below, no. The gap is five to ten years of know-how. That is the window where Lam Research and its oligopoly peers keep pricing power.
I have audited enough DeFi protocols to know that yield is compensation for risk. The same logic applies to equipment stocks. The 25 to 30x PE is not cheap. It is pricing in the AI growth story. The question is whether that story has legs. My read on the order flow says yes. The AI infrastructure build-out is still in the early innings. Training is moving to inference. Inference is moving to the edge. Each stage requires more chips, more memory, more advanced packaging. And each of those requires more equipment. The cycle is not ending. It is broadening.
Here is the takeaway. The equipment cycle is the purest expression of the AI trade. It is not about which chip wins. It is about who builds the tools for all of them. Lam Research is one of three names that matter. The risk is not the technology. It is the timing. If AI capex peaks in 2027, the stock will correct. But the correction will be a buying opportunity, not a thesis breaker. The structural demand is real. The oligopoly is stable. The service revenue is sticky. The math works. The only question is whether you have the patience to hold through the volatility. I do. I have been selling puts into panic for three years. Theta is my friend. And the equipment cycle is my alpha.